Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexilant for GERD-Related Non-Cardiac Chest Pain
NCT01637571Phase 4Withdrawn
- Sponsor
- University of Iowa
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexlansoprazole in gastroesophageal reflux disease (GERD), non-cardiac chest pain (NCCP), sponsored by University of Iowa. Status: withdrawn.
02
Drugs
dexlansoprazole
03
Conditions
gastroesophageal reflux disease (GERD)non-cardiac chest pain (NCCP)
Beyond the preview
Go deeper on NCT01637571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01637571.